Pharmaceutical Company Seeks Relief Through Construction Litigation

United States - Pennsylvania

Our firm represented one of the world’s largest pharmaceutical companies in litigation arising from the construction of its primary research and development facility. The facility consisted of nine connected buildings and laboratory facilities in Pennsylvania. The cumulative claims exceeded $30 million, and involved primarily disputes associated with the state-of-the-art HVAC system designed for pharmaceutical R&D work. The majority of HVAC ductwork collapsed shortly after start-up. The litigation also involved over 2000 disputed change orders and claims for damages related to a one year delay in completion. The matter was successfully resolved through private ADR – a mini-trial before a retired Board of Contract Appeals judge.

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.